The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease
Abstract
Abstract Mildly increased serum bilirubin has recently been suggested as a protective factor, possibly reducing the risk of coronary artery disease (CAD) by acting as an antioxidant. We tested this hypothesis by examining serum bilirubin concentrations and other coronary risk factors in 120 men and 41 women with early familial CAD and 155 control subjects. At screening, both cases and control subjects were 38 to 68 years old. Early familial CAD patients had experienced myocardial infarction, coronary artery bypass grafting, or coronary angioplasty by age 55 years for men and 65 for women and had another sibling similarly affected. The average total serum bilirubin concentration was 8.9±6.1 μmol/L in cases and 12.4±8.1 μmol/L in control subjects (P=.0001 for difference). In univariate analysis stratified by sex, serum bilirubin was strongly and inversely related to CAD risk, with relative odds of 0.4 to 0.1 (relative to the lowest quintile,P=.04 to .00001) in both men and women as bilirubin increased into the upper two quintiles. Multiple logistic regression analysis was performed including age, sex, smoking, body mass index, diabetes, hypertension, plasma measured LDL cholesterol, HDL cholesterol, triglycerides, and serum bilirubin as potential risk factors. Bilirubin entered as an independent protective factor with an odds ratio of 0.25 (P=.0015) for an increase of 17 μmol/L (1 mg/dL). The standardized logistic regression coefficient for bilirubin was −.33 compared with −.34 for HDL, suggesting that the protective effect of bilirubin on CAD risk in the population is comparable to that of HDL cholesterol. A history of cigarette smoking was associated with significantly lower serum bilirubin concentration and appeared to attenuate the protective effect of bilirubin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study
Hertog, M. G. L., Feskens, E. J. M., Kromhout, D., Hertog, M. G. L., Hollman, P. C. H., Hertog, M. G. L., & Katan, M. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)92876-u · Cited by 4,341
Bilirubin Is an Antioxidant of Possible Physiological Importance
Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1987) · Science · doi:10.1126/science.3029864 · Cited by 2,948
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282004 · Cited by 2,347
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine
Frankel, E. N., German, J. B., Kinsella, J. E., Parks, E., & Kanner, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90206-v · Cited by 1,647
Oxygen-radical absorbance capacity assay for antioxidants
Cao, G., Alessio, H. M., & Cutler, R. G. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90027-r · Cited by 1,605
Morrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,339
Inhibition of human LDL oxidation by resveratrol
Frankel, E. N., Waterhouse, A. L., & Kinsella, J. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92472-6 · Cited by 887
Antioxidant activity of albumin-bound bilirubin.
Stocker, R., Glazer, A. N., & Ames, B. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5918 · Cited by 766
Neuzil, J., & Stocker, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89449-8 · Cited by 508
Association of low serum concentration of bilirubin with increased risk of coronary artery disease
Schwertner, H. A., Jackson, W. G., & Tolan, G. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.1.18 · Cited by 474
Family history as an independent risk factor for coronary artery disease
Shea, S., Ottman, R., Gabrieli, C., Stein, Z., & Nichols, A. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80408-8 · Cited by 214
Morris, D. L. (1994) · JAMA · doi:10.1001/jama.272.18.1439 · Cited by 214
[31] Antioxidant activities of bile pigments: Biliverdin and bilirubin
Stocker, R., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86123-d · Cited by 207
HARATS, D., BENNAIM, M., DABACH, Y., HOLLANDER, G., STEIN, O., & STEIN, Y. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90130-5 · Cited by 191
Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease
Wu, L. L., Wu, J., Hunt, S. C., James, B. C., Vincent, G. M., Williams, R. R., & Hopkins, P. N. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.4.552 · Cited by 179
Self-citationBilirubin attenuates radical‐mediated damage to serum albumin
Neužil, J., & Stocker, R. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80353-v · Cited by 176
Genetic distances between the Utah Mormons and related populations.
McLellan, T., Jorde, L. B., & Skolnick, M. H. (1984) · PubMed · Cited by 174
Serum Carotenoids and Coronary Heart Disease
Morris, D. L. (1994) · JAMA · doi:10.1001/jama.1994.03520180063036 · Cited by 153
Yokode, M., Kita, T., Arai, H., Kawai, C., Narumiya, S., & Fujiwara, M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2344 · Cited by 145
Jorde, L. B. (1989) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1989.tb01803.x · Cited by 132
Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage
Wu, T.-W., Wu, J., Li, R., Mickle, D. A. G., & Carey, D. (1991) · Biochemistry and Cell Biology · doi:10.1139/o91-102 · Cited by 130
Hopkins, P. N., Williams, R. R., Kuida, H., Stults, B. M., Hunt, S. C., Barlow, G. K., & Ash, K. O. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91206-4 · Cited by 102
Self-citationThe Effects of Age, Smoking, and Alcohol on Routine Laboratory Tests
Chan‐Yeung, M., Ferreira, P. C., Frohlich, J. J., Schulzer, M., & Tan, F. (1981) · American Journal of Clinical Pathology · doi:10.1093/ajcp/75.3.320 · Cited by 93
Hopkins, P. N., Wu, L., Wu, J. T., Hunt, S. C., James, B. C., Vincent, G. M., & Williams, R. R. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1314 · Cited by 92
Self-citationVeganism, Clinical Findings and Investigations
Ellis, F. R., & MONTEGRIFFO, V. M. E. (1970) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/23.3.249 · Cited by 82
A rapid micro-scale procedure for determination of the total lipid profile.
Wu, L., Warnick, G. R., Wu, J. T., Williams, R. R., & Lalouel, J.-M. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.7.1486 · Cited by 66
Self-citationThe antioxidant role of bile pigments evaluated by chemical tests
Farrera, J., Jaumà, A., Ribó, J. M., Peiré, M. A., Puig‐Parellada, P., Choua, S., Bienvenüe-Goëtz, E., & Patrick, S. E. T. A. (1994) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)82013-1 · Cited by 65
Neonatal Hyperbilirubinemia at High Altitude
Leibson, C. L., Brown, M., Thibodeau, S., Stevenson, D. K., Vreman, H. J., Cohen, R. S., Clemons, G., Callen, W., & Moore, L. G. (1989) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1989.02150200145036 · Cited by 36
Bilirubin analysis—The state of the art and future prospects
Wu, T. W. (1984) · Clinical Biochemistry · doi:10.1016/s0009-9120(84)90101-2 · Cited by 34
Is a family history of coronary heart disease an independent coronary risk factor?
Conroy, R. M., Mulcahy, R., Hickey, N. J., et al. (1985) · Heart · doi:10.1136/hrt.53.4.378 · Cited by 27
White, G. L., Nelson, J. A., Pedersen, D. M., & ASh, K. (1981) · Clinical Chemistry · doi:10.1093/clinchem/27.6.1140 · Cited by 25
Gofin, J., Jd, K., Halfon, S.-T., Friedlander, Y., & Stein, Y. (1982) · PubMed · Cited by 15
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Wearable sensors: modalities, challenges, and prospects
Heikenfeld, J., Jajack, A., Rogers, J., Gutruf, P., Tian, L., Pan, T., Li, R., Khine, M., Kim, J., Wang, J., et al. (2018) · Lab on a Chip · doi:10.1039/c7lc00914c · Cited by 1,434
Bio-Integrated Wearable Systems: A Comprehensive Review
Ray, T. R., Choi, J., Bandodkar, A. J., Krishnan, S., Gutruf, P., Tian, L., Ghaffari, R., & Rogers, J. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00573 · Cited by 1,350
Biliverdin reductase: A major physiologic cytoprotectant
Barañano, D. E., Rao, M., Ferris, C. D., & Snyder, S. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252626999 · Cited by 1,088
Free heme toxicity and its detoxification systems in human
Kumar, S., & Bandyopadhyay, U. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.03.004 · Cited by 852
Metadata
- Authors
- Hopkins, P. N., Wu, L. L., Hunt, S. C., James, B. C., Vincent, G. M., & Williams, R. R.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1996-02
- Volume
- 16
- Issue
- 2
- Pages
- 250-255
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2123008059
- Cited by
- 367
- References
- 33
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.